The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

A month after a sickle cell pain crisis, columnist Dunstan Nicol-Wilson is learning how to trust his body again, which isn't easy.